The chemical class known as TAFA5 Activators encompasses a diverse group of compounds that can interact with cellular signaling pathways and regulatory mechanisms, which, in turn, can lead to the activation of the protein TAFA5. These activators are characterized by their ability to modulate various aspects of cellular function, such as gene expression, enzyme activity, and intracellular signaling cascades. For instance, some chemicals within this class can elevate levels of intracellular cAMP, thereby activating adenylyl cyclase, which can result in the upregulation of proteins that are responsive to cAMP response elements. Others can act as inhibitors of phosphodiesterase, leading to the accumulation of cAMP within the cell and thus can have a similar effect on cAMP-dependent pathways.
In addition to influencing second messenger systems, some members of the TAFA5 Activators class can interact with key signaling molecules and transcription factors, thereby affecting the transcriptional regulation of genes. This can include activation of receptors that bind to specific DNA sequences and initiate transcription, as well as inhibition of enzymes like histone deacetylases, which can lead to changes in chromatin structure and, consequently, gene expression. Kinase inhibitors within this class can alter kinase-dependent signaling pathways, which can have downstream effects on the expression and function of a range of proteins, including TAFA5. These chemicals can also modulate the activity of other signaling pathways, such as those regulated by GSK-3β, NF-κB, and various MAP kinases, which are integral to maintaining cellular homeostasis and responding to extracellular signals. Through these mechanisms, TAFA5 Activators can elicit changes in the cellular environment that facilitate the activation of TAFA5, thereby influencing its role within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases intracellular cAMP by activating adenylyl cyclase, which could possibly activate TAFA5 if it is regulated by cAMP response elements. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, which could possibly activate TAFA5 if TAFA5 is cAMP-responsive. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, which could possibly activate TAFA5 if TAFA5 expression is regulated by pathways involving this kinase. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
GSK-3β inhibitor that could possibly activate TAFA5 through Wnt signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Activates retinoic acid receptors, which could possibly activate TAFA5 if its promoter is responsive to these transcription factors. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $126.00 $210.00 $488.00 | 19 | |
Kinase inhibitor, which could possibly activate TAFA5 by altering signaling cascades that influence its expression or function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which could possibly activate TAFA5 by modulating PKC-dependent signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates NF-κB and other signaling molecules, which could possibly activate TAFA5 if it is regulated by NF-κB. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor that could possibly activate TAFA5 by increasing transcriptional accessibility. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that could possibly activate TAFA5 by affecting the ERK/MAPK signaling pathway. | ||||||